Prof. Dr. Katja Schenke-Layland currently holds a dual appointment as Professor of Biomedical Technologies and Regenerative Medicine at the University Women’s Hospital at the Eberhard Karls University Tübingen (UKT), and the Director of the Natural and Medical Sciences Institute (NMI) Reutlingen, Germany. Katja is also an Adjunct Associate Professor in the Department of Cardiology at UCLA, Los Angeles, USA, is the Co-Editor-in-Chief of Tissue Engineering, Part B, Reviews, and an Executive Editor for Advanced Drug Delivery Reviews, which is, one of the top journals in the field of advanced drug delivery. Katja is the Study Dean for Medical Technology at the UKT and sits on the board of multiple journals and biomedical associations. Katja is a biologist with a main interest in stem cell, developmental and extracellular matrix biology. Her work focuses on the translation of developmental processes into clinically relevant biomaterials and regenerative therapy strategies, and the development of diagnostic tools to discover and validate therapeutic candidates and diagnose diseases.